Appropriate use of virtual touch quantification and FibroScan® M and XL probes according to the skin capsular distance

Journal of Gastroenterology

Volumn 51, Issue 5, 2016, Pages 496-505

  Kumagai, Erina ^a,b,c   Korenaga, Keiko ^a   Korenaga, Masaaki ^a,b   Imamura, Masatoshi ^a   Ueyama, Misuzu ^a,b,c   Aoki, Yoshihiko ^a   Sugiyama, Masaya ^b   Murata, Kazumoto ^a,b   Masaki, Naohiko ^a,b   Kanto, Tatsuya ^a,b   Mizokami, Masashi ^a,b   Watanabe, Sumio ^c  

^a 1 7 1 Kohnodai   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Transient elastography; Virtual touch quantification; XL probe

Indexed keywords

ACOUSTIC RADIATION FORCE IMPULSE IMAGING; ADULT; AGED; ARTICLE; CHRONIC LIVER DISEASE; CLINICAL EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ELASTOGRAPH; FEASIBILITY STUDY; FEMALE; HEPATOBILIARY PARAMETERS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAPANESE (PEOPLE); LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER STIFFNESS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ACCURACY; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REAL TIME ULTRASOUND SCANNER; SKIN CAPSULE DISTANCE; ULTRASOUND TRANSDUCER; VERY ELDERLY; VIRTUAL TOUCH QUANTIFICATION; YOUNG ADULT; ADOLESCENT; ASIAN CONTINENTAL ANCESTRY GROUP; BIOPSY; CHRONIC DISEASE; COMPARATIVE STUDY; COMPLICATION; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC IMAGING; ELASTOGRAPHY; LIVER DISEASE; MULTIVARIATE ANALYSIS; PATHOLOGY; PROCEDURES; REPRODUCIBILITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BIOPSY; CHRONIC DISEASE; ELASTICITY IMAGING TECHNIQUES; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LIVER DISEASES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 84944526118     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-015-1127-3     Document Type: Article

References (22)

1. Sporea I, Gilja OH, Bota S, et al. Liver elastography—an update. Med Ultrason. 2013;15:304–14.
2. Yoshioka K, Hashimoto S. Can non-invasive assessment of liver fibrosis replace liver biopsy? Hepatol Res. 2012;42:233–40.
3. Castéra L. Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology. 2012;142:1293–302.
4. The French Metavir Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology. 1994;20:15–20.
5. Castéra L, Foucher J, Bernard PH, et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology. 2010;51:828–35.
6. Sirli R, Sporea I, Bota S, et al. A Factors influencing reliability of liver stiffness measurement using transient elastography (M-probe)-monocetric experience. Eur J Radiol. 2013;82:e313–6.
7. Myers RP, Pomier-Layrargues G, Kirsch R, et al. Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology. 2012;55:199–208.
8. Bota S, Sporea I, Sirli R, et al. Factors associated with the impossibility to obtain reliable liver stiffness measurements by means of acoustic radiation force impulse (ARFI) elastography-analysis of a cohort of 1031 subjects. Eur J Radiol. 2014;83:268–72.
9. Cassinotto C, Lapuyade B, Aït-Ali A, et al. Liver fibrosis: noninvasive assessment with acoustic radiation force impulse elastography—comparison with FibroScan M and XL probes and FibroTest in patients with chronic liver disease. Radiology. 2013;269:283–92.
10. Friedrich-Rust M, Hadji-Hosseini H, Kriener S, et al. Transient elastography with a new probe for obese patients for non-invasive staging of non-alcoholic steatohepatitis. Eur Radiol. 2010;20:2390–6.
11. de Lédinghen V, Vergniol J, Foucher J. Feasibility of liver transient elastography with FibroScan using a new probe for obese patients. Liver Int. 2010;30:1043–8.
12. Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology. 2002;123:1705–25.
13. Wong VW, Vergniol J, Wong GL, et al. Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease. Am J Gastroenterol. 2012;107:1862–71.
14. Brunt EM, Janney CG, Di Bisceglie AM, et al. Non-alcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467–74.
15. ®): applying the cut-offs of M probe to XL probe. Ann Hepatol. 2013;12:570–80.
16. ®. J Hepatol. 2012;56:833–9.
17. Durango E, Dietrich C, Seitz HK, et al. Direct comparison of the FibroScan XL and M probes for assessment of liver fibrosis in obese and nonobese patients. Hepat Med. 2013;5:43–52.
18. ®. J Hepatol. 2014;61:550–7.
19. Bota S, Sporea I, Sirli R, et al. Factors which influence the accuracy of acoustic radiation force impulse (ARFI) elastography for the diagnosis of liver fibrosis in patients with chronic hepatitis C. Ultrasound Med Biol. 2013;39:407–12.
20. Carrión JA, Puigvehí M, Coll S, et al. Applicability and accuracy improvement of transient elastography using the M and XL probes by experienced operators. J Viral Hepat. 2015;22:297–306.
21. Wong GL. Tansient elastography: kill two birds with one stone? World J Hepatol. 2013;5:264–74.
22. Myers RP, Pomier-Layrargues G, Kirsch R, et al. Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe. J Hepatol. 2012;56:564–70.